CVR 38273604Entrepreneurial company (IVS)Kunstnerisk skaben (900300)Secondary industries: Anden teknisk rådgivning (711290)København VFounded 21 Dec 2016
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Kragh Barfod IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexResult
0
DKK, annual report 2019
Equity
1
DKK, annual report 2019
Tomas Kragh Barfod100% of capital and votes, until 16 Jun 2022
Tomas Kragh Barfoduntil 20 Aug 2021
No current owner is registered.
100% of capital and votes21 Dec 2016 to 16 Jun 2022
Kragh Barfod IVS holds no Danish company now.
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR.
CVR 3860611510% to under 15% of capital and votes1 May 2017 to 31 Jan 2023
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2019, DKK: Operating profit 0, Result for the year 0
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2019, DKK: Total assets 1, Equity 1
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2017 | 2018 | 2019 |
|---|---|---|---|
| Operating profit | 0 | 0 | 0 |
| Result for the year | 0 | 0 | 0 |
| Equity | 0 | 0 | 0 |
| Total assets | 0 | 0 | 0 |
| Employees (average) | Not reported | 0 | Not reported |
| Credit metrics (Dandex calculations) | |||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Kragh Barfod IVS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 1 | None | 1 | None | 1 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
7 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Konkursbehandlingen afsluttet 16.06.2022, virksomheden opløst
Konkursdekret afsagt 02.12.2021 af Sø- og Handelsrettens Skifteretsafdeling
Likvidatorer:
Fratrådte:
Peter Wedel Ranch Krarup, den 02.12.2021.
Revision:
Likvidatorer:
Tiltrådte:
Sø- og Handelsrettens Skifteretsafdeling har udnævnt følgende likvidatorer: Peter Wedel Ranch Krarup, 1256 København K, den 16.09.2021.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 20.08.2021
Direktion:
Fratrådte:
Tomas Kragh Barfod, (adm. dir), den 20.08.2021.
Vedtægter ændret: 01.01.2021
Nyt navn: Kragh Barfod IVS
Vedtægter ændret: 25.04.2017
Nyt navn: Kragh Barfod Holding IVS
Ny adresse: c/o Tomas Barfod, Valdemarsgade 37, 1. tv, 1665 København V
Formål ændret: Selskabets formål er at drive et holding selskab
Stiftelsesdato: 21.12.2016.
Seneste vedtægtsdato: 21.12.2016.
Kapital:
kr. 1,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1,00 til kurs 100,00, fuldt indbetalt.
Stifter:
Tomas Barfod, den 21.12.2016.
Direktion:
Tomas Kragh Barfod (adm. dir), den 21.12.2016.
Virksomheden tegnes af en direktør.
Første regnskabsår:
21.12.2016 - 31.12.2017.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er udvikling og salg af teknologibaserede sundhedsløsninger med henblik på at forbedre sundhed og velvære i offentlige og private organisation samt i samfundet generelt. Selskabets daglige virke er uadskilleligt fra vores overordnede ambition om at have en positiv indvirkning på folkesundheden generelt. KOMPIS tror på kroppen. Kroppen er klog og fortjener betænksom brug, vores sundhedsløsninger sigter mod at bruge og kommunikere til kroppen på bedst mulig vis. Vi vil give folk redskaberne til at betjene bevægelsesapparatet med størst mulig kompetence. KOMPIS tror på videnskab. Vores indhold og forretningsgang er informeret af seneste og bedste forskning inden for det humanfysiologiske felt. Hos KOMPIS leverer vi en sund før en flot krop. KOMPIS tror på medansvar.
P-number 1022027235Valdemarsgade 37, 1665 København V